Novavax Inc (NVAX) is a publicly traded Healthcare sector company. As of September 23, 2026, NVAX trades at $10.95 with a market cap of $1.72B and a P/E ratio of -7.20. NVAX moved +4.13% today. Year to date, NVAX is +61.16%; over the trailing twelve months it is +22.10%. Its 52-week range spans $5.01 to $11.97. Analyst consensus is neutral with an average price target of $11.33. Rallies surfaces NVAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NVAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $10.95 |
| Market Cap | $1.72B |
| P/E Ratio | -7.20 |
| EPS | $-1.52 |
| Dividend Yield | 0.11% |
| 52-Week High | $11.97 |
| 52-Week Low | $5.01 |
| Volume | 6.82M |
| Avg Volume | 0 |
| Revenue (TTM) | $413.80M |
| Net Income | $-247.73M |
| Gross Margin | 78.60% |
3 analysts cover NVAX: 0 strong buy, 1 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.33.